ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1008
    C-X-C Motif Chemokine 10 (CXCL10) as a Transcriptomic Biomarker of Psoriatic Arthritis Susceptibility
  • Abstract Number: 1567
    Cachexia in Systemic Lupus Erythematosus
  • Abstract Number: 364
    Calcium Pyrophosphate Crystal Arthritis During Hospitalizations: A Prospective, Crystal-Proven Case Series
  • Abstract Number: 2820
    Calcium/ Calmodulin – Dependent Protein Kinase IV Associates with Phosphofructokinase to Promote Glycolysis and Limit IL-2 Production
  • Abstract Number: 483
    Can a Single Question on Functional Impairments Facilitate the Diagnosis of Early Inflammatory Arthritis? A Cross-Sectional Derivation and Validation Study in Two Early Arthritis Recognition Clinics
  • Abstract Number: 1194
    Can an MDHAQ (Multidimensional Health Assessment Questionnaire) 60-Symptom Checklist to Monitor Early Medication Outcomes (MDHAQ/MEMO60) Detect Adverse Events of High-Risk Medications?
  • Abstract Number: 2505
    Can Biologics “Prevent” the Development of Psoriatic Arthritis in Psoriasis Patients? Data from a Large University Hospital Cohort in Argentina
  • Abstract Number: 613
    Can Fecal Calprotectin Predict Future Development of Inflammatory Bowel Disease in Axial Spondyloarthritis Patients? – TReasure Real-Life Preliminary Data
  • Abstract Number: 790
    Can High ANA Titre Combined with Clinical Features Predict Developing Autoimmune Conditions in Children?
  • Abstract Number: 1250
    Can Patient-Reported Outcomes and Disease Activity Scores Predict Patient Acceptable Symptom State in Adult-Onset Still’s Disease?
  • Abstract Number: 283
    Can Synovial Hypertrophy in the Feet Without Doppler Change During Treatment – Results from a Longitudinal Study of Rheumatoid Arthritis Patients Initiating Biological DMARD
  • Abstract Number: 1570
    Can the Montreal Cognitive Assessment (MoCA) Improve the Automated Neuropsychological Assessment Metrics (ANAM) Performance in Screening for Cognitive Impairment in Lupus Patients?
  • Abstract Number: 1714
    Can We Predict Early Relapses in Adult IgA Vasculitis?
  • Abstract Number: 2227
    Can We Predict Hypophosphatasia-Mutation Result Based on Alkaline Phosphatase Serum Levels?
  • Abstract Number: 802
    Canakinumab Improves Patient-Reported Outcomes in Patients with Recurrent Fever Syndromes: Results from a Phase 3 Trial
  • Abstract Number: 2785
    Cancer Risk in a Large Inception SLE Cohort: Effects of Age, Smoking, and Medications
  • Abstract Number: 1082
    Cancer Risk in Patients with Ankylosing Spondylitis: A Nationwide Population-based Dynamic Cohort Study from Korea
  • Abstract Number: 2929
    Cannabis Use Among Patients in a Large US Rheumatic Disease Registry
  • Abstract Number: 1683
    Cardiac Involvement of Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss): Initial Manifestations and Outcomes Based on Data from a Monocenter Patient Cohort
  • Abstract Number: 745
    Cardiac Involvements Are Related to Poor Prognosis in Patients with Takayasu’s Arteritis in China
  • Abstract Number: 326
    Cardiac Sarcoidosis Awareness: Are We Underdiagnosing?
  • Abstract Number: 2327
    Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors and the Role of Auto-antibodies
  • Abstract Number: L04
    Cardiovascular Disease Risk in Calcium Pyrophosphate Deposition Disease
  • Abstract Number: 2439
    Cardiovascular Impact of Hyperuricemia in Patients with Psoriatic Arthritis
  • Abstract Number: 1078
    Cardiovascular Risk Awareness in Patients with Rheumatic Diseases: A Case-Control Study
  • Abstract Number: 2136
    Cardiovascular Risk Evaluation in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Results from the “Cardiovascular Obesity and Rheumatic DISease (CORDIS)” Study Group of the Italian Society of Rheumatology
  • Abstract Number: 2332
    Cardiovascular Risk Factors in Rheumatoid Arthritis: Prevalence, Comparison of Risk Calculators and Subclinical Atherosclerosis in Indian Patients
  • Abstract Number: 2676
    Cardiovascular Treatment and the Incidence of Giant Cell Arteritis (GCA) – a Population-Based Case-Control Study
  • Abstract Number: 349
    Carotid Atherosclerosis and Sonographic Signs of Urate Crystal Deposits in Patients with Gout: An Association Study
  • Abstract Number: 2761
    Cartilage Thickness Modification with Sprifermin in Knee Osteoarthritis Patients Translates into Symptomatic Improvement over Placebo in Patients at Risk of Further Structural and Symptomatic Progression: Post-Hoc Analysis of a Phase II Trial
  • Abstract Number: 2411
    Casting a Wide Net: Comparing Strategies for Recruiting 18-35-year-olds with Rheumatic Disease as Study Participants
  • Abstract Number: 1776
    Causal Effect of TNF-α, IL-12p70, IL-17 Levels on the Risk of Psoriatic Arthritis: A Mendelian Randomization Study
  • Abstract Number: 1089
    Causes of Death in ANCA-Associated Vasculitis According to ANCA Type
  • Abstract Number: 1574
    Causes of Death in SLE: Analysis of Inpatient Death from 2000-2018 in a Tertiary Care Hospital in India
  • Abstract Number: 2258
    Causes of Influenza Vaccine Hesitancy in Rheumatoid Arthritis and Adults with Juvenile Idiopathic Arthritis
  • Abstract Number: 1764
    CCL25, a Novel Fibroblast and Macrophage Chemoattractant That Potentiates RA Bone Erosion
  • Abstract Number: 1987
    CCN3 Regulates Macrophage Function in MSU-induced Inflammation
  • Abstract Number: 687
    CCP Autoantibody Positive SLE Patients Show Unique Enrichments in SLE Criteria and Autoantibody Biomarkers That Vary by Race
  • Abstract Number: 1072
    CCR2+ Circulating Monocytes Contribute to the Survival of ADSC in Bleomycin-Induced Skin Fibrosis
  • Abstract Number: 1064
    CD123+ Plasmacytoid Dendritic Cells from Systemic Sclerosis Patients Are Susceptible to the Cytotoxic Activity of Tagraxofusp, a CD123-Targeted Therapy
  • Abstract Number: 101
    CD126 Negative CD4+Foxp3+ Cell Represents a Superior Treg Subset in Treating Autoimmune Diseases
  • Abstract Number: 1971
    CD39 Produced from Human Gingiva-Derived Mesenchymal Stem Cells Regulates the Balance of Osteoclasts and Osteoblasts Through Wnt / β-catenin Pathway in Osteoporosis
  • Abstract Number: 1069
    CD4+ T Helper Cell Populations with High PD-1 Expression Are Expanded in Systemic Sclerosis
  • Abstract Number: 65
    CD6 Modulation Ameliorates Skin and Kidney Disease in a Spontaneous Murine Model of SLE
  • Abstract Number: 2894
    CD6-ALCAM Signaling Is Upregulated in Kidneys with Lupus Nephritis and Is Associated with Disease Activity
  • Abstract Number: 115
    CD8+ Cytotoxic T Lymphocytes Are Clonally-expanded in IgG4-related Disease and Home to Affected Tissues
  • Abstract Number: 1403
    CDAI Analysis of Dose Escalation in a Trial of Infliximab for Rheumatoid Arthritis
  • Abstract Number: 2887
    Cell-bound Complement Activation Products in Combination with Low Complement C3 or C4 Have Superior Diagnostic Performance in Systemic Lupus Erythematosus
  • Abstract Number: 2626
    Cell-free Mitochondrial DNA Levels in Granulomatosis with Polyangiitis
  • Abstract Number: 84
    Cenerimod, a Potent and Selective Sphingosine-1-Phosphate Receptor 1 Modulator, Controls Systemic Autoimmunity and Organ Pathology in Mouse Models of Systemic Lupus Erythematosus and Sjögren’s Syndrome
  • Abstract Number: 2519
    Cenerimod, a Potent, Selective and Orally Active Sphingosine 1-phosphate Receptor 1 Modulator, Reduced Blood Antibody-secreting Cells in Patients with SLE
  • Abstract Number: 448
    Central Sensitization in Patients with Rheumatoid Arthritis Using the Central Sensitization Inventory
  • Abstract Number: 1507
    Certolizumab Pegol Improves Work and Household Productivity and Social Participation over 1 Year of Treatment in Patients with Non-Radiographic Axial Spondyloarthritis
  • Abstract Number: 1508
    Certolizumab Pegol-Treated Patients with Non-Radiographic Axial Spondyloarthritis Demonstrate Improvements in Sleep Quality and Other Patient Reported Outcomes
  • Abstract Number: 1273
    Certolizumab Therapy in Patients with Uveitis During Pregnancy: Multicenter Study
  • Abstract Number: 1641
    Change in Calcinosis over 1 Year Using the SCTC Radiologic Scoring System for Calcinosis of the Hands in Patients with Systemic Sclerosis
  • Abstract Number: 546
    Change in Rheumatoid Arthritis (RA)-Related Autoantibody Profile and Risk of Disease Flare After Withdrawal of Therapy in Patients with Early RA Treated with Abatacept and MTX
  • Abstract Number: 864
    Change in Scleroderma Skin Histology Correlates with the Combined Response Index in Systemic Sclerosis (CRISS) in Patients with Early, Diffuse Cutaneous Systemic Sclerosis
  • Abstract Number: 2768
    Changes in B Cell Profile as a Marker of Clinical Remission to TNF Inhibitors in Patients with Rheumatoid Arthritis
  • Abstract Number: 2602
    Changes in Fecal Microbiota Composition After Fecal Microbiota Transplantation in Systemic Sclerosis
  • Abstract Number: 780
    Changes in MiR-17-92 Cluster Expression Link Systemic Juvenile Idiopathic Arthritis, Monocyte-to-Macrophage Differentiation, and Interferon Regulation
  • Abstract Number: 1285
    Changes in Nail-fold Capillary Abnormalities, and Serum FGF and VEGF Levels in Dermatomyositis Patients with anti-MDA5 Antibody During the Clinical Course
  • Abstract Number: 1162
    Changes in Novel Composite Scores of Disease Activity and Cumulative Damage Are Prognostic of Accelerated Knee Osteoarthritis: Data from the Osteoarthritis Initiative
  • Abstract Number: 2399
    Changes in the Initial Usage Pattern of Biologic Disease-modifying Antirheumatic Drugs in Rheumatic Diseases During the past Twelve Years: A Real-world Setting Analysis
  • Abstract Number: 2632
    Changing Trends in the Management of ANCA-associated Vasculitis at an Academic Medical Center
  • Abstract Number: 797
    Characteristics of Coexisting Localized Scleroderma and Juvenile Idiopathic Arthritis
  • Abstract Number: 2162
    Characteristics of Patients with Rheumatoid Arthritis Undergoing Primary Total Joint Replacement: A 14-year Trend Analysis (2004-2017)
  • Abstract Number: 1081
    Characteristics of Patients with Seropositive or Seronegative Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from the US-Based Corrona Rheumatoid Arthritis and Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registries
  • Abstract Number: 714
    Characteristics of Patients with Systemic Sclerosis in the Rheumatology Informatics System for Effectiveness (RISE) Registry
  • Abstract Number: 2447
    Characteristics of Psoriasis Patients with Subclinical Signs of Musculoskeletal Involvement Detected by Fluorescence Optical Imaging and Confirmed by MRI-assessment
  • Abstract Number: 1027
    Characterization of Antibody Secreting Cells in Patients with Active Systemic Lupus Erythematosus
  • Abstract Number: 1926
    Characterization of DOCK8 as a Novel Gene Associated with Macrophage Activation Syndrome
  • Abstract Number: 529
    Characterization of Remission in Patients with Rheumatoid Arthritis Treated with Upadacitinib or Comparators
  • Abstract Number: 1956
    Characterizing Arthritis Related to Immune Checkpoint Inhibitors Using Synovial Fluid and Matched Blood
  • Abstract Number: 96
    Characterizing the Brain T Cell Receptor Repertoire in Neuropsychiatric Lupus
  • Abstract Number: 2743
    Characterizing the Epigenomic Landscape of Psoriasis Patients Destined to Develop Psoriatic Arthritis
  • Abstract Number: 2157
    Checkpoint Inhibitor-Associated Arthritis: Phenotype, Steroid Dose, Serology and Survival
  • Abstract Number: 1710
    Chemokine and Cytokine Tear Profile of Patients with IgG4-Related Disease
  • Abstract Number: 9
    Chemokine CXCL 10 Gene Expression as a Potential Activity Biomarker of Systemic Lupus Erythematosus
  • Abstract Number: 749
    Childhood Takayasu Arteritis: Characteristics and Outcomes of a Mexican Cohort
  • Abstract Number: 746
    Childhood-Onset Takayasu’s Arteritis (TAK) Is Clinically More Active, However Has Similar Cumulative Damage Compared to Adult-Onset TAK
  • Abstract Number: 1775
    Cholesterol Sequestering in Macrophages Contributes to the Lipid Paradox in Chronic Arthritis
  • Abstract Number: 56
    Choline Metabolite Is Associated with Inflammation in Arthritis in the Elderly
  • Abstract Number: 773
    Chondrocytes Influence Fibroblast-like Synoviocytes from Patients with Juvenile Idiopathic Arthritis, Through the Abrogation of TGFβ Signaling, to Delay Cell Differentiation and Maturation
  • Abstract Number: 402
    Chronic Disease Course and IVIg-dependance in Long-term Follow-up of Anti-HMGCR Immune-mediated Necrotizing Myopathy
  • Abstract Number: 256
    Chronic Musculoskeletal Pain and Its Initial Management in Children, Adolescents and Young Adults in the United States
  • Abstract Number: 1772
    Chronotherapy Using Baricitinib Attenuates Collagen-induced Arthritis in Mice
  • Abstract Number: 51
    Cigarette Smoking Has Different Impacts on ACPA and RF Production Depending on Shared Epitope Allele Status in Japanese RA Patients; A Study with the Two Independent Japanese Cohorts (IORRA and KURAMA)
  • Abstract Number: 822
    Cigarette Smoking Is a Risk Factor for ANCA-Associated Vasculitis
  • Abstract Number: 50
    Circulating 25(OH)D, LL-37 and Antimicrobial Protein and Peptide (APP) Levels Are Altered Prior to Onset of Rheumatoid Arthritis
  • Abstract Number: 2421
    Circulating CCR7loPD-1hi Follicular Helper T Cells Indicate Disease Activity and Glandular Inflammation in Patients with Primary Sjögren’s Syndrome
  • Abstract Number: 1661
    Circulating Cell Free DNA Released from Eosinophils Is a Practical Biomarker in Patients with Eosinophilic Granulomatosis with Polyangiitis
  • Abstract Number: 1034
    Circulating MicroRNAs as Potential Biomarkers for Monitoring the Response to In Vivo Treatment with Rituximab in Systemic Lupus Erythematosus
  • Abstract Number: 2005
    Circulating Mitochondrial Danger-Associated Molecular Patterns as Novel Biomarkers of Disease Activity and Inflammation in Rheumatoid Arthritis
  • Abstract Number: 968
    Circulating PR3-Specific B Cells in Patients with Active ANCA-Associated Vasculitis
  • Abstract Number: 488
    Citrullinated Antigens with Multiple Citruline Similar Motif Could Be Used for RA Diagnosis
  • Abstract Number: 7
    Citrullination of Interleukin 6 Augments Its Pro-inflammatory Capacity and Signaling Potency Through Interleukin-6 Receptor in Rheumatoid Arthritis
  • Abstract Number: 2859
    Citrulline Reactive B Cells Are Present in the Lungs of Early Untreated RA
  • Abstract Number: 8
    CKD-506, a Selective Histone Deacetylase (HDAC) 6 Inhibitor, Regulates Inflammatory Responses Through NF-kB and AP-1 Signaling
  • Abstract Number: 1068
    Classical Monocytes from African Ancestry Patients with Systemic Sclerosis Show Transcription and Energy Regulation Gene Expression Signatures
  • Abstract Number: 365
    Classifying Pseudogout Using Machine Learning Approaches with Electronic Health Record Data
  • Abstract Number: 1779
    CLEC5A/MDL-1 Is Critical for Inflammatory Arthritis and Skin Inflammation
  • Abstract Number: 2772
    Clinical and Biological Changes in Rheumatoid Arthritis Patients Exposed to an Anti-inflammatory Diet
  • Abstract Number: 494
    Clinical and Biomarker Factor Associations with Symptoms and Future Development of RA: TIP-RA Collective
  • Abstract Number: 2907
    Clinical and Functional Outcomes Among Rheumatoid Arthritis Patients Switching Between JAK1-Selective Inhibitor Upadacitinib and Adalimumab Following Insufficient Response
  • Abstract Number: 143
    Clinical and Genetic Factors Associated with Thrombosis or Pregnancy Morbidity of Antiphospholipid Antibody-Positive Systemic Lupus Erythematosus Patients
  • Abstract Number: 675
    Clinical and Serological Lupus Activity Before and After Developing End Stage Renal Disease
  • Abstract Number: 1590
    Clinical and Sociodemographic Associates of Depression and Anxiety in Systemic Lupus Erythematosus
  • Abstract Number: 684
    Clinical Biomarkers at Renal Flare Are Associated with Histologic Changes in Repeat Renal Biopsy in Patients with Biopsy-proven Lupus Nephritis
  • Abstract Number: 2586
    Clinical Characteristics and Survival in Systemic Sclerosis-mixed Connective Tissue Disease and Systemic Sclerosis-overlap Syndrome
  • Abstract Number: 1700
    Clinical Characteristics and the Level Disease Activity of Behcet´s Disease in China: A Study Based on Smart System of Disease Management (SSDM)
  • Abstract Number: 1480
    Clinical Characteristics and Treatment Profiles of Patients with Ankylosing Spondylitis Who Initiated Secukinumab and Other Biologics: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
  • Abstract Number: 2641
    Clinical Characteristics of a Cohort of Patients with a Self-Reported Diagnosis of Granulomatosis with Polyangiitis or Microscopic Polyangiitis
  • Abstract Number: 673
    Clinical Characteristics of Lymphadenopathy in Systemic Lupus Erythematous: A Case Control Study from a Tertiary Care Center
  • Abstract Number: 1467
    Clinical Characteristics of Primary Sjögren’s Syndrome in Adult Patients Diagnosed at Age Less Than or Equal to 35 Years versus Those over 35 Years of Age
  • Abstract Number: 1868
    Clinical Correlations of Autoantibodies Against Heat Shock Cognate 71 kDa Protein in Patients with Juvenile Dermatomyositis
  • Abstract Number: 2757
    Clinical Effectiveness of Ultrasound-guided Intra-articular Corticosteroid and Local Anaesthetic Injections for Hip Osteoarthritis: A Randomised Controlled Trial (HIT)
  • Abstract Number: 2576
    Clinical Evidence Supporting Therapeutic Potential of Activating the Immune Checkpoint Receptor BTLA in SLE
  • Abstract Number: 2725
    Clinical Factors Distinguishing Between Pediatric Tumors with Arthritis at Onset and JIA: Preliminary Analysis of the ONCOREUM Study
  • Abstract Number: 1262
    Clinical Features of Elderly-onset Adult Still’s Disease
  • Abstract Number: 397
    Clinical Features of Polymyositis and Dermatomyositis Patients with Severe Dysphagia
  • Abstract Number: 2123
    Clinical Features of Prosthetic Joint Infections in Patients with Rheumatic Diseases vs Osteoarthritis
  • Abstract Number: 302
    Clinical Impact of a Rheumatology Musculoskeletal Ultrasound Clinic at a U.S. Academic Center
  • Abstract Number: 2581
    Clinical Impact of Decreasing Hydroxychloroquine Dose According to the 2016 American Academy of Ophthalmology Guidelines in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1827
    Clinical Implications of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus
  • Abstract Number: 396
    Clinical Manifestations and Comparison of Subtypes of Juvenile Idiopathic Inflamatory Myopathies: Data from the REMICAM Registry
  • Abstract Number: 1248
    Clinical Manifestations and Management of US Patients with SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis) Syndrome, a Retrospective Study
  • Abstract Number: 869
    Clinical Manifestations of Patients with Eosinophilic Granulomatosis with Polyangiitis in a Large North American Cohort
  • Abstract Number: 2665
    Clinical Outcomes of Patients with Giant Cell Arteritis and Polymyalgia Rheumatica Symptoms Treated with Tocilizumab in Routine Clinical Practice
  • Abstract Number: 1836
    Clinical Outcomes of Patients with Giant Cell Arteritis with Polymyalgia Symptoms Only vs Cranial Symptoms Only Treated with Tocilizumab or Placebo in a Randomized Clinical Trial
  • Abstract Number: 1719
    Clinical Phenotypes in Relapsing Polychondritis in a Prospective Cohort
  • Abstract Number: 1449
    Clinical Phenotyping of Patients with Primary Sjögren’s Syndrome Using Salivary Gland Ultrasonograhpy
  • Abstract Number: 174
    Clinical Presentation and Disease Course Evaluation of Mono- and Bilateral Knee Arthritis: Results from the Leiden Early Arthritis Clinic Cohort
  • Abstract Number: 2461
    Clinical Presentation and Treatment of Oligoarticular Psoriatic Arthritis in Canada: High Frequency of Smaller Joint Involvement
  • Abstract Number: 652
    Clinical Relevance According to Staining Patterns and Titers of Antinuclear Antibody
  • Abstract Number: 515
    Clinical Responses in Patients with Inadequate Response to bDMARDs upon Treatment with Upadacitinib
  • Abstract Number: 1299
    Clinical Significance of Magnetic Resonance Imaging Derived Femur Bone Shape in Young Adults
  • Abstract Number: 2309
    Clinical Study of Peripheral Blood Lymphocyte Subsets in Patients with Rheumatoid Arthritis Complicated with Osteoporosis
  • Abstract Number: 2923
    Clinical Subsets in Giant Cell Arteritis
  • Abstract Number: 2674
    Clinical Symptoms and Associated Vascular Imaging Findings in Takayasu’s Arteritis Compared to Giant Cell Arteritis
  • Abstract Number: 1160
    Clinical Trials in Rheumatoid Arthritis Have Inadequate Racial/Ethnic, Gender and Age Diversity: A Systematic Review
  • Abstract Number: 1178
    Clinical Utility of DECT in the Diagnosis of Gout at Mayo Clinic in Florida
  • Abstract Number: 1735
    Clinical Variables Influencing Prednisone Dosing Towards the Development of Corticosteroid Treatment Algorithms in Pediatric Proliferative Lupus Nephritis
  • Abstract Number: 2066
    Clinical, Serologic and Morphologic Features of Interstitial Pneumonia with Autoimmune Features (IPAF): A Single Center Experience
  • Abstract Number: 1552
    Clinically Meaningful Improvement in Skin and Nail Psoriasis in Bio-naïve Active Psoriatic Arthritis Patients Treated with Intravenous Golimumab: Results Through Week 52 from a Phase-3 Study
  • Abstract Number: 1820
    Clinically Relevant Deficits in Performance Tests in Patients with Axial Spondyloarthritis(axSpA) – Collecting Questionnaires Is Insufficient
  • Abstract Number: 2197
    Clinically Relevant Improvements in Knee Osteoarthritis Pain with Diclofenac Sodium Gel 1%
  • Abstract Number: 2855
    Clinically Relevant Patient Clusters Identified by Machine Learning Tools in a Large Database from the Secukinumab Psoriatic Arthritis Clinical Development Program
  • Abstract Number: 2546
    Clinician’s Simple Opinion of SLE Disease Progress: Used in a Clinical Trial
  • Abstract Number: 2687
    Clinicopathologic Associations in a Large International Cohort of Patients with Giant Cell Arteritis
  • Abstract Number: 2821
    Clonal Expansion of a Specific Subset of Cytotoxic CD4+T Cells and Tissue Apoptosis in Patients with IgG4-related Disease
  • Abstract Number: 1048
    Clonally Expanded CD4+ Cytotoxic T Cells, Endothelial Cell Apoptosis and the Pathogenesis of Early Systemic Sclerosis
  • Abstract Number: 791
    Closing the Seronegative Gap in Pediatric Localized Scleroderma and Systemic Sclerosis
  • Abstract Number: 2636
    Cluster Analysis for Classification of Japanese Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Subgroup Analysis of Nationwide Cohort Studies
  • Abstract Number: 676
    Cluster Profiling of Patients in a Real-World Data Set with Systemic Lupus Erythematosus and Their Associated Treatments
  • Abstract Number: 2774
    Cluster-based Spondyloarthritis Phenotypes Defined at Baseline Are Predictive of Different Severity Outcomes at 5-Year in the DESIR Cohort
  • Abstract Number: 912
    Co-morbidities Associated with Discordance Between Structural Severity and Pain in Osteoarthritis: Implications for Clinical Trial Design in OA – a Post-Hoc Analysis of Data from Two Randomized Controlled Trials
  • Abstract Number: 2070
    Co-morbidities in Patients with OA and RA: Results from a Large US Rheumatic Disease Registry
  • Abstract Number: 1792
    Cognitive Dysfunction (CD) and Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Primary Antiphospholipid Syndrome (PAPS)
  • Abstract Number: 1736
    Cognitive Impairment in Childhood-Onset Systemic Lupus Erythematosus: Early Detection with MRI Spectroscopy and Its Association with MOG Antibodies
  • Abstract Number: 1622
    Cognitive Impairments in SLE Negatively Related to Participation and Quality of Life: A Systematic Review
  • Abstract Number: 360
    Colchicine Prophylaxis of Gout Flares When Commencing Allopurinol Is Very Cost Effective: A Health Economic Analysis
  • Abstract Number: 2664
    Color Doppler Ultrasound for the Diagnosis of Giant Cell Arteritis in Montreal: A Canadian Single Center Experience
  • Abstract Number: 2126
    Combined Detection of Cytokines and Biomarkers Improve the Diagnostic Performance of Bacteria Infection in Rheumatoid Arthritis
  • Abstract Number: 2287
    Combined First-Trimester Serum BAFF and sFlt-1 Levels as an Early Biomarker of Spontaneous Abortion
  • Abstract Number: 2884
    Combined Trajectories of Fatigue and Disease Activity in an Inception Cohort of Lupus Patients over 10 Years
  • Abstract Number: 1963
    Combining Clinical and Candidate Gene Data into a Risk Score for Azathioprine-Associated Leukopenia in Routine Clinical Practice
  • Abstract Number: PP07
    Coming to Terms with Lupus: How Learning to Listen to My Body and Letting it Tell Me What to Do Improved My Quality of Life
  • Abstract Number: 1811
    Commonly Used Drugs in Rheumatology May Alter Anti-Tumoral Response to Immune Checkpoint Inhibitors
  • Abstract Number: 1852
    Community-level Deprivation Index: Impact on Discharge Destination After Elective Hip Replacement
  • Abstract Number: 1754
    Comorbidities and Treatments in United States Youth with Chronic Musculoskeletal Pain
  • Abstract Number: 245
    Comorbidities, Health Care Utilization, and Cost of Care in Systematic Lupus Erythematous Increase with Disease Severity During 1 Year Before and After Diagnosis: A Real-World Cohort Study in the United States, 2004–2015
  • Abstract Number: 874
    Comparative Analysis Between ANCA-associated Interstitial Lung Disease and Interstitial Pneumonitis with Autoimmune Features
  • Abstract Number: 2378
    Comparative Analysis of Clinical, Laboratory and Therapeutic Strategies Among Blacks with Rhupus, SLE and RA
  • Abstract Number: 1397
    Comparative Effectiveness of Tocilizumab in Combination with Methotrexate versus Tumor Necrosis Factor Inhibitors (TNFis) in Combination with Methotrexate in Patients with Rheumatoid Arthritis with Prior Exposure to TNFis
  • Abstract Number: 1496
    Comparative Effectiveness of Ustekinumab and TNF Inhibitors in Patients with Psoriatic Arthritis in a Real-world, Multicenter Study
  • Abstract Number: 20
    Comparative Efficacy of Beta-2-Glycoprotein I Domain V Structural Analogue Variants in Preventing Antiphospholipid Antibody-Mediated Endothelial Cell Activation
  • Abstract Number: 355
    Comparative Risk of Cardiovascular Events in US Veterans with Gout Treated with Febuxostat versus Allopurinol
  • Abstract Number: L01
    Comparative Risk of Hospitalized Serious Infection in Patients with Psoriasis and Psoriatic Arthritis: A Population-Based Multi-Database Study
  • Abstract Number: 2782
    Comparative Risks of Cardiovascular Disease Among SLE Patients Receiving Immunosuppressive Medications
  • Abstract Number: 2643
    Comparative Study of Renal Transplantation Due to Rapidly Progressive Glomerulonephritis (RPGN): Study of 42 Patients from a Single Tertiary Centre
  • Abstract Number: 2253
    Comparing Patient and Provider Perspectives on Long Term Biologic Use and Tapering in Stable, Well-Controlled Rheumatoid Arthritis
  • Abstract Number: 241
    Comparing Patients with Fibromyalgia Syndrome with Non-Fibromyalgia Rheumatic Disease Patients Regarding Exercise
  • Abstract Number: 540
    Comparing Real-world Retention Rates in a Matched Cohort of Rheumatoid Arthritis Patients Who Either Remained on the Etanercept Originator or Switched to a Biosimilar
  • Abstract Number: 557
    Comparing Symptoms, Treatments Patterns, and Quality of Life of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Patients: Findings from a US Survey
  • Abstract Number: 182
    Comparing the Generalizability of Cardiovascular Risk in Different Rheumatoid Arthritis Cohorts
  • Abstract Number: 2483
    Comparison Between Composite Activity Indices to Assess Clinical Response to Biological Therapy in Patients with Psoriatic Arthritis
  • Abstract Number: 2302
    Comparison Between Fibromyalgia and Neuropathic Pain in Patients with Established Rheumatoid Arthritis
  • Abstract Number: 2624
    Comparison Between Long-Term and Conventional Rituximab-Maintenance Treatments: Results of a Placebo-Controlled Randomized Trial
  • Abstract Number: 2652
    Comparison Between Transmural and Isolated Periadventitial And/or Adventitial Inflammation at Temporal Artery Biopsy: A Single Center Cohort of Biopsy-Positive GCA with Long Term Follow-up
  • Abstract Number: 2654
    Comparison of Aortitis and Non-Inflammatory Thoracic Aortic Aneurysms Undergoing Open Surgical Repair
  • Abstract Number: 2920
    Comparison of Arterial Patterns of Disease in Takayasu’s Arteritis and Giant Cell Arteritis
  • Abstract Number: 1645
    Comparison of Automated Capture and Analysis System of Sublingual Microvessels and Nailfold Videocapillarscopy for Microvascular Assessment in Systemic Sclerosis
  • Abstract Number: 2649
    Comparison of Biopsy Proven Giant Cell Arteritis in North America and South Europe: A Population-Based Study
  • Abstract Number: 279
    Comparison of Carotid Ultrasound and Coronary Artery Calcium Score in Cardiovascular Risk Stratification of Patients with Inflammatory Rheumatic Diseases
  • Abstract Number: 485
    Comparison of Clinical Features, Synovial Histology and Immunohistochemistry in Seropositive Arthralgia, Rheumatoid Arthritis, and Osteoarthritis
  • Abstract Number: 945
    Comparison of Clinical Manifestations in IgG4 Related Disease Patients with/without Aortitis/Periaortitis and Periarteritis: A Prospective Cohort Study of 587 Patients with IgG4-RD Disease
  • Abstract Number: 1452
    Comparison of Clinical Phenotype, Serological Characteristics and Histologic Features Between Males and Females Patients with Primary Sjögren’s Syndrome (pSS)
  • Abstract Number: 2494
    Comparison of Comorbidity in Spondyloarthritis: Influence on Inflammatory Activity in Patients with Psoriatic Arthritis
  • Abstract Number: 150
    Comparison of Debate vs. Lecture to Teach Medical Students Pediatric Rheumatology
  • Abstract Number: 1634
    Comparison of Different Pulmonary Hypertension Screening Algorithms in Patients with Systemic Sclerosis
  • Abstract Number: 1475
    Comparison of Different Remission Indices in Patients with Psoriatic Arthritis: A Post Hoc Analysis of Data from Phase 3 Tofacitinib Studies
  • Abstract Number: 1256
    Comparison of FMF Patients with Age of Onset Before 20 versus 40 Years and Over
  • Abstract Number: 2366
    Comparison of Healthcare Resource Utilization (HCRU) and Costs of Type 2 Diabetes Mellitus (T2DM)-Related Complications in TNFi-Experienced Medicare Beneficiaries with Rheumatoid Arthritis (RA) and T2DM Who Switch to Abatacept or Other Targeted Disease-Modifying Anti-Rheumatic Drugs
  • Abstract Number: 1409
    Comparison of Healthcare Resource Utilization and Costs of Type 2 Diabetes Mellitus (T2DM)-Related Complications in Medicare Beneficiaries with Rheumatoid Arthritis (RA) and T2DM Who Initiated Treatment with Abatacept versus Other Targeted Disease-Modifying Anti-Rheumatic Drugs
  • Abstract Number: 1801
    Comparison of Infection-Related Hospitalization Risk and Cost in TNFi-Experienced Medicare Beneficiaries with Rheumatoid Arthritis Treated with Abatacept or Other Targeted Disease-Modifying Anti-Rheumatic Drugs
  • Abstract Number: 2874
    Comparison of Malignancy and Mortality Rates Between Tofacitinib and Biologic DMARDs in Clinical Practice: Five-Year Results from a US-Based Rheumatoid Arthritis Registry
  • Abstract Number: 2067
    Comparison of Medication New User Definitions in Multi-Specialty EMR Data
  • Abstract Number: 602
    Comparison of Men and Women with Axial Spondyloarthritis in the US-Based Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
  • Abstract Number: 1669
    Comparison of Mizoribine with Azathioprine in Efficacy and Safety for ANCA-Associated Vasculitis
  • Abstract Number: 2639
    Comparison of Patient Self-reported Data to Physician-driven Cohorts in Patients with Eosinophilic Granulomatosis with Polyangiitis
  • Abstract Number: 433
    Comparison of PROMIS Computerized Adaptive Testing-Administered Item Banks versus Fixed Short Forms in Juvenile Myositis
  • Abstract Number: 1427
    Comparison of Real-World Persistence of Subcutaneously Administered Biologic Disease-Modifying Antirheumatic Drug Therapies Among Patients with Rheumatoid Arthritis Switching from Another Biologic
  • Abstract Number: 845
    Comparison of Rituximab-Associated Hypogammaglobulinemia Rates in Patients with Systemic Rheumatologic Conditions
  • Abstract Number: 2099
    Comparison of Single and Dual Latent Tuberculosis Screening Strategies Before the Initiation of Biologic and Targeted Therapy in Rheumatological Patients in Hong Kong
  • Abstract Number: 1442
    Comparison of Sustained Clinical Remission And/or Low Disease Activity Rate Between Rapidly and Gradually De-escalation of Abatacept in Rheumatoid Arthritis
  • Abstract Number: 1437
    Comparison of the Efficacy and Safety of Abatacept in Rheumatoid Arthritis Patients with and Without Interstitial Lung Disease
  • Abstract Number: 2107
    Comparison of the Management and Prognosis of Pneumonia in Patients with and Those Without Rheumatoid Arthritis Using the Japanese Diagnosis Procedure Combination Database
  • Abstract Number: 688
    Comparison of the Physicians’ Clinical Diagnosis and the EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a Multiethnic Cohort
  • Abstract Number: 1825
    Comparison of the Thrombosis Risk Score with Triple Positivity in SLE Thrombosis
  • Abstract Number: 1447
    Comparison of Ultra High‐resolution Ultrasound (UHFUS) of Labial Salivary Glands and Conventional Salivary Gland Ultrasonography in Primary Sjögren’s Syndrome Assessment
  • Abstract Number: 2688
    Comparisons of Strategies for Diagnostic Assessment in Giant Cell Arteritis: Results from an International Observational Cohort
  • Abstract Number: 669
    Complement Activation in Probable Systemic Lupus Erythematosus (pSLE) May Predict Progression to SLE Defined by Fulfillment of ACR Classification Criteria
  • Abstract Number: 2132
    Complement Component 3 as Biomarker of Cardiometabolic Risk in Rheumatic Diseases: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Systemic Lupus Erythematosus
  • Abstract Number: 642
    Complement Deposition C4d on Platelets Is Associated with Vascular Events in Systemic Lupus Erythematosus
  • Abstract Number: 2895
    Complement Protein CL-K1 at High Concentrations Protects Against the Development of Lupus Nephritis
  • Abstract Number: 787
    Complement Protein Levels Reflect Disease Activity in Juvenile Idiopathic Arthritis
  • Abstract Number: 323
    Compliance with Hydroxychloroquine Dosage According to 2016 American Academy of Ophthalmology (AAO) Guidelines: A Study with 6591 Patients
  • Abstract Number: 2146
    Complications of Immune Checkpoint Inhibitor Therapy in Patients with and Without Pre-existing Rheumatologic Disease
  • Abstract Number: 1931
    Comprehensive Characterization of the Immune Infiltrate of Skin Biopsies from Cutaneous Lupus Erythematosus Patients Using Single Cell RNAseq
  • Abstract Number: 1041
    Computational Methods for Drug Repositioning of Systemic Sclerosis Using Gene Fold-Change and Network Analyses
  • Abstract Number: 2590
    Computer Vision Applied to Dual Energy Computed Tomography Images for Precise Calcinosis Cutis Quantification in Patients with Systemic Sclerosis
  • Abstract Number: 243
    Concomitant Fibromyalgia in Patients with Other Rheumatic Diseases and Response to Treatment
  • Abstract Number: 1537
    Concomitant Treatment with Methotrexate Does Not Increase the Efficacy of Ustekinumab or TNF Inhibitors in Psoriatic Arthritis: Results from a Real-world, Multicenter Study
  • Abstract Number: 429
    Concordance Between Physician and Patient Assessment of Disease Activity in Rheumatoid Arthritis Using Disease Activity Score: Phase II Results
  • Abstract Number: 1309
    Concordance of Baseline Pain Measures (Across Two Reporting Instruments) Influences Treatment Effect: Post Hoc Analysis of a Phase 3 Randomized Controlled Trial of Triamcinolone Acetonide Extended-Release in Patients with Knee Osteoarthritis
  • Abstract Number: 977
    Conditional Deletion of MKL1 Inhibits Osteoclast Formation and Bone Erosions in Collagen Induced Arthritis Mice
  • Abstract Number: 1180
    Confirmation of Manual Cartilage Segmentation Findings by Automated Segmentation: Retrospective Analysis of MRI Images from a Sprifermin Phase II Study
  • Abstract Number: 1391
    Connective Tissue Remodeling Is Differently Modulated by Tocilizumab versus Methotrexate Monotherapy in Patients with Early RA: The AMBITION Study
  • Abstract Number: 2386
    Consensus Statement and Recommendations on Methotrexate Use in Combined Therapy with Biological or Targeted Synthetic Disease Modifying Drugs in Patients with Rheumatoid Arthritis
  • Abstract Number: 1365
    Construct Validation of PROMIS Short Form and Profile-29 T-Scores with SF-36 in Rheumatoid Arthritis Patients Treated for 1 Year: Results from a Real World Evidence-Based Study in the United States
  • Abstract Number: 2191
    Construct Validity of OMERACT Ultrasound Knee Scores with Pain, Other Symptoms, Radiographic and MRI Findings
  • Abstract Number: 2523
    Contemporary Prescription Opioid Use and Predictors Among Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1818
    Continuing versus Withdrawing Ixekizumab in Patients with Psoriatic Arthritis Who Achieved Sustained Minimal Disease Activity: Results from the SPIRIT-P3 Study
  • Abstract Number: 464
    Continuous Decrease in Serum RF Titer During Anti-TNF Therapy Was Associated with Suppression in Progression of RA Joint Damage
  • Abstract Number: 2294
    Contraception Documentation Rates in Women with Rheumatic Diseases on Teratogenic Medications in an Academic Rheumatology Clinic
  • Abstract Number: 1630
    Contribution of Chest Wall Muscle Atrophy to Decline of Forced Vital Capacity in Patients with Systemic Sclerosis-associated Interstitial Lung Disease
  • Abstract Number: 1958
    Contribution of MOCS on Xanthinuria Type III and Its Clinical Significance for Screening
  • Abstract Number: 417
    Contribution of Pain Relief to Function, Fatigue, and Quality of Life When Inflammation Is Controlled in Patients with Rheumatoid Arthritis
  • Abstract Number: 2250
    Contribution of Personality Traits, Psychological Factors and Health Related Quality of Life on Medication Adherence in Patients with RA
  • Abstract Number: 2692
    Coronary Artery Disease in a Population-Based Cohort of Biopsy-Proven Giant Cell Arteritis in Southern Sweden
  • Abstract Number: 223
    Correlation Between Heart Rate Variability Parameters and Circulating Neuropeptides in Fibromyalgia
  • Abstract Number: 427
    Correlation Between Patient Reported Outcomes Measurement Information System (PROMIS) and RAPID3 in Rheumatoid Arthritis Patients Starting a New Biologic DMARD
  • Abstract Number: 1635
    Correlation Between Raynaud’s Condition Score, Nailfold Videocapillaroscopy and Laser Speckle Contrast Analysis in Secondary Raynaud’s Phenomenon Due to Systemic Sclerosis
  • Abstract Number: 682
    Correlation Between the Lupus Foundation of America – Rapid Evaluation of Activity in Lupus (LFA-REAL) Patient Reported Outcome (PRO) and Health-Related Quality of Life (HRQoL) and Other PROs in a Primarily Mestizo Population
  • Abstract Number: 1359
    Correlation of Ultrasound Guided Synovial Biopsies and Surgical Synovial Biopsies in Patients with Inflammatory Arthritis
  • Abstract Number: 692
    Correlation of Urinary Soluble CD163 Levels with Clinicopathological Features in Lupus Nephritis: Its Role as a Potential Biomarker
  • Abstract Number: 1170
    Cortical Bone Erosion in the 2nd Metacarpal Bone Head: Association with Its Bone Mineral Density by HR-pQCT in Rheumatoid Arthritis Patients
  • Abstract Number: 2891
    Cost-effectiveness of Duloxetine for Knee OA Patients Whose Pain Can’t Be Controlled by NSAIDs
  • Abstract Number: 1419
    Cost-per-Responder Analysis of Sarilumab for the Treatment of Moderately-to-Severely Active Rheumatoid Arthritis (RA)
  • Abstract Number: 1849
    Cost-related Prescription Non-adherence Is Associated with Patient-reported Outcomes of Systemic Lupus Erythematosus Activity and Damage: The Michigan Lupus Epidemiology & Surveillance (MILES) Cohort
  • Abstract Number: 2603
    Course of Progressive Lung Fibrosis in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in the EUSTAR Database
  • Abstract Number: 23
    Covalent High Molecular Weight HMGB1 Complexes in Muscle Regeneration: Implications in Inflammatory Myopathy
  • Abstract Number: 2748
    Cracking a Novel Profibrotic Molecular Mechanism: lncRNA H19X and DDIT4L Crosstalk
  • Abstract Number: 2831
    Cracks in Your Referral Process? Find Your Sustainable Solution Here
  • Abstract Number: 1371
    Create an Algorithm of Outcome Forecasting and Decision Making for RA Treatment: Data Mining and Machine Learning via the Smart System of Disease Management (SSDM)
  • Abstract Number: 444
    Criterion Validity of the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) Questionnaire and FLARE-RA Cut-offs for Clinical Decision Making: International Collaboration
  • Abstract Number: 887
    Critical Role of the Cholinergic System Involvement in Osteoarthritis
  • Abstract Number: 2057
    Cross-sectional Associations of Multiple Joint Osteoarthritis in the Osteoarthritis Initiative
  • Abstract Number: 2075
    Cross-sectional Study and Mendelian Randomization Analysis of Diet in Six Prevalent Autoimmune Diseases
  • Abstract Number: 800
    Cryopyrin-Associated Periodic Syndrome in Korea: 19 Years of Experience
  • Abstract Number: 2903
    Cryopyrin-Associated Periodic Syndrome Treated with Canakinumab – Long-Term Follow-up Data Documents Sustained Safety and Remission
  • Abstract Number: 2615
    Cumulative Incidence, Survival and Predictors of Pulmonary Arterial Hypertension in Disease Subsets of Systemic Sclerosis: PAH Is Not Increased in Limited vs Diffuse Patients by Adjusted Competing Risk Analysis
  • Abstract Number: 2500
    Current Smoking Status Increases the Risk of Axial Psoriatic Arthritis: An Explanation to Smoking Paradox
  • Abstract Number: 1640
    Cutaneous and Musculoskeletal Clinical Characterization of a Cohort of Patients with Chronic Graft-versus-host Disease
  • Abstract Number: 775
    Cutaneous Gene Expression Signatures in Juvenile Myositis Reveal a Prominent IFN Signature in Lesional Skin
  • Abstract Number: 861
    Cutaneous Lupus Erythematosus Disease Area & Severity Index (CLASI) Demonstrates Thresholds for Detection of Treatment Response in a Phase-2, Placebo-Controlled Trial of Ustekinumab in SLE
  • Abstract Number: 534
    CXCL13 Serum Levels and Circulating Follicular Helper T-Cells Decrease After Co-stimulation Blockade with Abatacept in Rheumatoid Arthritis
  • Abstract Number: 1047
    CXCL4-L1 Levels Are Elevated in Systemic Sclerosis Patients and Correlate with Pulmonary Arterial Hypertension and Capillaroscopic Indices of Vascular Damage
  • Abstract Number: 1410
    Cycling of Tumor Necrosis Factor-α (TNF-α) Inhibitors versus Switching to Different Μechanism of Αction in Rheumatoid Arthritis Patients with Inadequate Response to TNF-α Inhibitor: A Bayesian Network Meta-analysis
  • Abstract Number: 2593
    Cyclophosphamide for the Treatment of Skin Fibrosis in Systemic Sclerosis: A Systematic Review
  • Abstract Number: 1705
    Cyclophosphamide Therapy for the Neurologic Involvement of Behçet’s Disease – Is It Superior to Azathioprine in Preventing Relapses?
  • Abstract Number: 15
    CYR61/TGF-β Axis Promotes Adventitial Fibrosis of Takayasu Arteritis in the IL-17 Mediated Inflammatory Microenvironment
  • Abstract Number: 2527
    Cytokine and Autoantibody Profiles During Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1781
    Cytokine Dependence of Enthesis-resident Lymphocytes in Murine Spondyloarthritis
  • Abstract Number: 543
    Cytokine Signaling Pathways Inhibited by Different Biologics in Rheumatoid Arthritis Patients
  • Abstract Number: 1070
    Cytokine Signatures Differentiate Systemic Sclerosis Patients at High versus Low Risk for Pulmonary Arterial Hypertension
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences